{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:59:19Z","timestamp":1771707559949,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.annepidem.2009.01.016","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T05:34:41Z","timestamp":1238650481000},"page":"226-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Scientific Basis for Eliminating Folic Acid\u2013Preventable Spina Bifida: A Modern Miracle from Epidemiology"],"prefix":"10.1016","volume":"19","author":[{"suffix":"Jr.","given":"Godfrey P.","family":"Oakley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2009.01.016_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ajcn\/82.2.279","article-title":"Science-based micronutrient fortification: which nutrients, how much, and how to know?","volume":"82","author":"Rosenberg","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.annepidem.2009.01.016_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0140-6736(91)90133-A","article-title":"Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group","volume":"338","author":"MRC Vitamin Study Research Group","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.01.016_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(83)92654-5","article-title":"Further experience of vitamin supplementation for prevention of neural tube defect recurrences","volume":"1","author":"Smithells","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.01.016_bib4","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJM199212243272602","article-title":"Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation","volume":"327","author":"Czeizel","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2009.01.016_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/oxfordjournals.bmb.a071187","article-title":"Causation of neural tube defects: clues from epidemiology","volume":"30","author":"Leck","year":"1974","journal-title":"Br Med Bull"},{"key":"10.1016\/j.annepidem.2009.01.016_bib6","article-title":"Folic acid metabolism and human embryopathy","volume":"1254","author":"Hibbard","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.01.016_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(83)92337-1","article-title":"Vitamins and neural tube defects","volume":"2","author":"Oakley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.01.016_bib8","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1001\/jama.1988.03410210053035","article-title":"Periconceptional use of multivitamins and the occurrence of neural tube defects. [see comment]","volume":"260","author":"Mulinare","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.01.016_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5694\/j.1326-5377.1989.tb136723.x","article-title":"Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia","volume":"150","author":"Bower","year":"1989","journal-title":"Med J Aust"},{"key":"10.1016\/j.annepidem.2009.01.016_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM198908173210704","article-title":"The absence of a relation between the periconceptional use of vitamins and neural-tube defects.\u00a0National Institute of Child Health and Human Development Neural Tube Defects Study Group. [see comment]","volume":"321","author":"Mills","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2009.01.016_bib11","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.1989.03430200091032","article-title":"Multivitamin\/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. [see comment]","volume":"262","author":"Milunsky","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.01.016_bib12","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.282.6275.1509","article-title":"Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects","volume":"282","author":"Laurence","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.annepidem.2009.01.016_bib13","first-page":"513","article-title":"Centers for Disease Control and Prevention. Use of folic acid for prevention of spina bifida and other neural tube defects\u20131983-1991","volume":"40","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-14","key":"10.1016\/j.annepidem.2009.01.016_bib14","first-page":"1","article-title":"Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects","volume":"41","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annepidem.2009.01.016_bib15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199911113412001","article-title":"Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention","volume":"341","author":"Berry","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2009.01.016_bib16","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.285.23.2981","article-title":"Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects","volume":"285","author":"Honein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.annepidem.2009.01.016_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa067103","article-title":"Reduction in neural tube defects after folic acid fortification in Canada","volume":"357","author":"De Wals","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.annepidem.2009.01.016_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ajmg.a.20230","article-title":"Latin American Collaborative Study of Congenital Malformations (ECLAMC). Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America","volume":"123A","author":"Castilla","year":"2003","journal-title":"Am J Med Genet A"},{"issue":"RR-13","key":"10.1016\/j.annepidem.2009.01.016_bib19","first-page":"1","article-title":"Folic acid and prevention of spina bifida and anencephaly. 10 years after the U.S. Public Health Service recommendation","volume":"51","author":"Erickson","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.annepidem.2009.01.016_bib20","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/jn\/133.10.3166","article-title":"Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile","volume":"133","author":"Hertrampf","year":"2003","journal-title":"J Nutr"},{"key":"10.1016\/j.annepidem.2009.01.016_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bdra.20442","article-title":"Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa","volume":"82","author":"Sayed","year":"2008","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.annepidem.2009.01.016_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.ede.0000260493.24573.15","article-title":"When will we eliminate folic acid-preventable spina bifida?","volume":"18","author":"Oakley","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.annepidem.2009.01.016_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(99)03227-4","article-title":"Trends in serum folate after food fortification","volume":"354","author":"Lawrence","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.annepidem.2009.01.016_bib24","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1056\/NEJM199905133401901","article-title":"The effect of folic acid fortification on plasma folate and total homocysteine concentrations","volume":"340","author":"Jacques","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2009.01.016_bib25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.105.570846","article-title":"Improvement in stroke mortality in Canada and the United States, 1990 to 2002","volume":"113","author":"Yang","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.annepidem.2009.01.016_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/bdra.20504","article-title":"Update on prevention of folic acid-preventable spina bifida and anencephaly","volume":"85","author":"Bell","year":"2009","journal-title":"Birth Defects Research Part A"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279709000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279709000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:05:50Z","timestamp":1760925950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279709000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1047279709000465"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2009.01.016","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Scientific Basis for Eliminating Folic Acid\u2013Preventable Spina Bifida: A Modern Miracle from Epidemiology","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2009.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}